Skip to main content
TipRanks
Go Ultimate75% OFF

Kyntra Bio (KYNB) Stock Forecast & Price Target

1,066 Followers
See the Price Targets and Ratings of:

KYNB Analyst Ratings

Strong Buy
4Ratings
3Buy1Hold0Sell
Based on 4 analysts giving stock ratings to Kyntra Bio in the past 3 months

KYNB Stock 12 Month Forecast

$39.67▲(1053.10% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Kyntra Bio in the last 3 months. The average price target is $39.67 with a high forecast of $43.00 and a low forecast of $35.00. The average price target represents a 1053.10% change from the last price of $3.44.
Highest Price Target$43.00Average Price Target$39.67Lowest Price Target$35.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for KYNB
Price TargetArticle
Maxim Group$35buy917.44%UpsideInitiated10/13/26
H.C. Wainwright$43buy1150.00%UpsideReiterated10/05/26
Lake Street$41buy1091.86%UpsideInitiated09/17/26
William Blair―hold―Reiterated08/31/26
Oppenheimer$35buy917.44%UpsideReiterated08/14/26
Rodman & Renshaw$30buy772.09%UpsideInitiated06/09/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
QUITAchieve Life Sciences
PALIPalisade Bio
KRSAKorsana Biosciences
HELPHelus Pharma
IRLAIRulya Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kyntra Bio

3 Months
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate4/13 ratings generated profit
31%
Average Return
-17.32%

Copying Matthew Keller's trades and holding each position for 3 Months would result in 30.77% of your transactions generating a profit, with an average return of -17.32% per trade.

1 Year
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate0/13 ratings generated profit
0%
Average Return
-35.65%

Copying Matthew Keller's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -35.65% per trade.

2 Years
Matthew Keller
Matthew KellerH.C. Wainwright
Success Rate0/13 ratings generated profit
0%
Average Return
-54.48%

Copying Matthew Keller's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -54.48% per trade.

KYNB Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for KYNB
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy34564
Buy00000
Hold12220
Sell00000
Strong Sell00000
total46784

In the current month, KYNB has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. KYNB average Analyst price target in the past 3 months is 39.67.

KYNB Financial Forecast

$-6$8$22$36$50Q4 2025Q2 2026Q3 2026
High$-2.82
Consensus$-3.55
Low$-4.31

KYNB Earnings Forecast

Next quarter’s earnings estimate for KYNB is -$3.55 with a range of -$4.31 to -$2.82. The previous quarter’s EPS was $2.96. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1.5M$-171,000.5$1.1M$2.4M$3.7MQ4 2025Q2 2026Q3 2026
High$3.4M
Consensus$1.77M
Low$1.18M

KYNB Sales Forecast

Next quarter’s sales forecast for KYNB is $1.77M with a range of $1.18M to $3.40M. The previous quarter’s sales results were -$1.47M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

KYNB Stock Forecast FAQ

What is KYNB’s average 12-month price target, according to analysts?
Based on analyst ratings, Kyntra Bio’s 12-month average price target is $39.67.
What is KYNB’s upside potential, based on the analysts’ average price target?
Kyntra Bio has 1053.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KYNB a Buy, Sell or Hold?
Kyntra Bio has a consensus rating of Strong Buy which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is Kyntra Bio’s price target?
The average price target for Kyntra Bio is $39.67. This is based on 4 12-month price targets, issued in the past 3 months. The highest analyst price target is $43.00, the lowest forecast is $35.00. The average price target represents a 1053.10% increase from the current price of $3.44.
What do analysts say about Kyntra Bio?
Kyntra Bio’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of KYNB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.